Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Says Added Food Ingredients May Exceed GRAS Parameters

This article was originally published in The Tan Sheet

Executive Summary

An FDA guidance says some ingredients used at high levels in food products are generally recognized as safe for their intended, traditional use. But the trend of increasing the density of ingredients “raises questions as to whether these higher levels and other new conditions of use are safe.”

You may also be interested in...



FDA Liquid Supplement/Beverage Guidance Defines Distinctions

The CFSAN guidance goes into greater detail on distinguishing liquid supplements from beverages, addressing stakeholders’ complaint about a 2009 draft. “This tends to really draw a bright line between the two different categories,” says CRN Regulatory Counsel Rend Al-Mondhiry.

FD&C Act Works For Functional Foods; Lawyer Offers Labeling Advice

FDA considers the statutory scheme authorized in the Food, Drug and Cosmetic Act sufficient to address regulation of functional foods, but the Center for Food Safety and Applied Nutrition continues examining whether to establish a distinct framework

CBD Safety And Hemp Farming Have Equal Space In Rep. Harris’ Concerns

“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.

Topics

UsernamePublicRestriction

Register

PS107046

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel